Literature DB >> 11794709

Acute myeloid leukemia with t(11;19)(q23;p13) developing in an adult T-cell leukemia patient treated with combined chemotherapy including etoposide.

N Kanemura, H Tsurumi, T Hara, T Yamada, M Sawada, T Naito, H Moriwaki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11794709     DOI: 10.1007/bf02982097

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  5 in total

1.  Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II.

Authors:  J Pedersen-Bjergaard; P Philip
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

Review 2.  Possible association between adult T-cell leukemia/lymphoma and acute myeloid leukemia.

Authors:  K Tsukasaki; T Koba; M Iwanaga; K Murata; T Maeda; S Atogami; H Nakamura; Y Yamada; S Kamihira; M Tomonaga
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

3.  Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy.

Authors:  C M Rubin; D C Arthur; W G Woods; B J Lange; P C Nowell; J D Rowley; J Nachman; B Bostrom; E S Baum; C R Suarez
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

4.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

Authors:  C H Pui; R C Ribeiro; M L Hancock; G K Rivera; W E Evans; S C Raimondi; D R Head; F G Behm; M H Mahmoud; J T Sandlund
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

Review 5.  Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia.

Authors:  H Nakamura; T Ishizaki; T Itoyama; H Soda; Y Yoshida; Y Yamada; K Kuriyama; N Sadamori; M Tomonaga
Journal:  Br J Haematol       Date:  1994-01       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.